Related Experiment Videos
Comment on "The frequency of breast cancer screening: results from the UKCCCR Randomised Trial"
European Journal of Cancer (Oxford, England : 1990)
|July 12, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Androgens in women after allogeneic hematopoietic cell transplantation: impact of chronic GvHD and glucocorticoid therapy.
Bone marrow transplantation·2016
ESTIMATES OF BREAST CANCER GROWTH RATE FROM MAMMOGRAMS AND ITS RELATION TO TUMOUR CHARACTERISTICS.
Radiation protection dosimetry·2015
The interaction of fingermark deposits on metal surfaces and potential ways for visualisation.
Forensic science international·2015
Breast cancer detection in digital breast tomosynthesis and digital mammography-a side-by-side review of discrepant cases.
The British journal of radiology·2014
Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy.
The British journal of radiology·2012
Direct Tumor-Adipocyte Contact as a Prognostic Biomarker in Resected Pancreatic Ductal Adenocarcinoma.
European journal of cancer (Oxford, England : 1990)·2026
Biomarker-defined benefit from FLOT plus nivolumab in metastatic gastroesophageal cancer: Extended follow-up and immune-inflammatory markers of the phase II IKF-AIO-moonlight trial.
European journal of cancer (Oxford, England : 1990)·2026
Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: Results from the first-in-human STESIDES study.
European journal of cancer (Oxford, England : 1990)·2026
Geneo study: Comprehensive genomic profiling versus limited local reimbursed NGS panels within the belgian Precision initiative.
European journal of cancer (Oxford, England : 1990)·2026
Assessing the effect of chemotherapy dose reductions and time delay on event-free survival in Ewing Sarcoma: A retrospective analysis of the Euro Ewing 2012 trial.
European journal of cancer (Oxford, England : 1990)·2026
70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups.
European journal of cancer (Oxford, England : 1990)·2026